Drug "Lerivon". imiyalelo ukusetyenziswa kwayo.

"Lerivon" - ichiza enxulumene lakhula. Ukuze bakwazi aqhelane isakhiwo yeencindi isoloko incamathele ichiza "Lerivon" umyalelo.

Ubume be-"lerivon" yi ichiza into esebenzayo - hydrochloride mianserin (30 mg), kunye nezithako abangabancedani: wemagniziyam stearate, iitapile starch, meliltsellyuloza, dust kalloidny anhydrous, calcium phosphate, titanium dioxide (E 171), macrogol, hypromellose.

Le mianserin into esebenzayo unxulumene khompawundi piperazino-azepine ezo iikhemikhali ezinxulumene lakhula tricyclic. "Lerivon" Uvale alpha2 receptor kwaye abangaphangeliyo reuptake of norepinephrine, ngaleyo ndlela kwande ugqithiso noradrenergic ebuchotsheni. Kwakhona esikubone intsebenziswano serotinovymi kunye zemizwa kwinkqubo luvo. Ichiza kwakhona siqala ukusebenza anxiolytic, nto leyo ibaluleke kakhulu unyango iingxaki ixhala kunye zokulala, ezo zibangelwa urhulumente ngokubanzi edandathekileyo womntu.

Okuqhotyoshelwe ichiza "Lerivon" La mazwi abonisa ukuba ichiza ukunyamezeleka kakuhle zizigulane kunye izifo nemithambo yegazi, kwakunye nabantu abadala. Ngelo amathamo ukuba therapeutically olusebenzayo "Lerivon" liye phantse nafuthe nemithambo yegazi. Yena eziziimpawu umsebenzi anticholinergic. It lineziphumo ngaphantsi cardiotoxic kwi libanda, ngaphezu lakhula tritseklicheskie. "Lerivon" alibhekiseli ukuya bachasene umfutho kunye arhente sympathomimetic.

iziyobisi elisetyenzisiwe "Lerivon 'kwi misinga of etiologies ezahlukeneyo. Noko ke, kukho izinto ezimbalwa Izimo. Ukuze wazi abathengi kunye nabo eziqhotyoshelwe ichiza "Lerivon" umyalelo. Yifundeni ngokweenkcukacha, ungabona ukuba akunakwenzeka ukuba ukwamkela "Lerivon": xa kwimeko hypersensitivity ukuya into esebenzayo - mianserin okanye naziphi na izakhi encedisayo; abantwana abafikisayo ongaphantsi kweminyaka eli-18; yezifo kwesibindi kunye ephula kakhulu imisebenzi yalo.

Amanyathelo ukuthatha eli iindleko kweziyobisi kubantu abane kwezintso, isibindi, ukungaphumeleli, ukusilela intliziyo esinganyangekiyo, engile-ukuvalwa neglaucoma, isifo seswekile, hypertrophy prostatic. Ngokubhekisele ixesha ukukhulelwa kunye lokwaphusa, iqhotyoshelwe ichiza "Lerivon" umyalelo ikuvumela ukuba ufunde ulwazi eksperimenti zaqhutywa izilwanyana kwaye iqokelelwe ngokubhekiselele umntu, idatha limited. Ngenxa yesi sizathu, kwafunyaniswa ukuba mianserin akukho neontalnogo okanye umonakalo intrauterine. Kuye kwafunyaniswa ukuba mianserin wendele ngobisi lwebele ngezixa engephi. Noko ke, nangona oku phambi kokwenza "Lerivon" xa ukondla okanye ukukhulelwa, kufuneka uthelekise inzuzo ichiza kunye ingozi kwimveku nomntwana.

Unako ukufunda ngale mveliso "Lerivon" ncomo amayeza phambi kokuba ukusetyenziswa ngqo ichiza. Ukususela ncomo uyakwazi maxa wambi ukufumana ulwazi luncedo. Umzekelo, uyakwazi ukufunda ngezinye zeziphumo ebezingalindelekanga: rhoqo kakhulu somnolence; maxa wambi ubunzima bomzimba inyusiwe; kuchazwa ngokuthi kwiimeko ezinqabileyo kakhulu agranulocytosis, uphuhliso leukopenia ingathityazwa, amahlaba, arthralgia, gynecomastia, nokudumba, ukonakala umsebenzi zesibindi.

Okuqhotyoshelwe ichiza "imiyalelo Lerivon 'ukuba ukusetyenziswa ayenzelwanga iinjongo self-unyango kunye reference kuphela. Kuyimfuneko ukuba zikuthathele ingqalelo oku ingqalelo phambi kokuba nokusebenzisa iziyobisi. Treatment amiselwe ngugqirha.